News SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific Officer Continue Reading Previous SpringWorks Therapeutics Appoints Dr. Tai-An Lin as Chief Scientific OfficerNext New Data From an Influenza Challenge Study Further Support the Prophylactic Potential of INNA-051 to Accelerate Viral Clearance Related Stories News Everest Medicines Reports 1H 2026 Results, Enters New Phase as Growth Accelerates and Innovation Gains Momentum News Aurentis Capital Group Announces Technology-Driven Trading Platform for Global Markets News TMX Group Limited Completes Acquisition of RAFI Indices from Research Affiliates News Focus Graphite Chairman Converts Final C$835,000 Loan to Equity at a Premium to Market News Hong Kong emerges as top professional services platform for Mainland enterprises going global News Cybersecurity Excellence Awards 2026 Announces Dual Recognition for Principal AI Engineer Harsh Verma